EyePoint Pharmaceuticals ...
(EYPT)
undefined
undefined%
At close: undefined
7.96
6.49%
After-hours Dec 13, 2024, 05:55 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 |
| Revenue | 46.02M | 41.40M | 36.94M | 34.44M | 20.36M | 2.96M | 7.54M | 1.62M | 26.57M | 3.47M | 2.14M | 3.53M | 4.96M | 23.05M | 12.16M | 3.48M | 2.23M | 1.47M | 629.52K | 265.23K | 74.35K | 516.32K |
| Cost of Revenue | 4.63M | 8.33M | 8.18M | 5.82M | 2.69M | 18.50M | - | 815.00K | 14.38M | 78.00K | 9.57M | 7.00M | 7.04M | - | - | - | - | - | - | - | - | - |
| Gross Profit | 41.39M | 33.08M | 28.76M | 28.61M | 17.68M | -15.54M | 7.54M | 805.00K | 12.18M | 3.40M | -7.43M | -3.48M | -2.07M | 23.05M | 12.16M | 3.48M | 2.23M | 1.47M | 629.52K | 265.23K | 74.35K | 516.32K |
| Operating Income | -75.07M | -78.94M | -55.28M | -37.29M | -47.86M | -26.27M | -18.58M | -21.77M | 6.42M | -13.49M | -12.03M | -25.21M | -10.00M | 9.09M | -4.64M | -24.90M | -35.54M | -27.68M | -10.25M | -6.24M | -3.60M | -1.80M |
| Interest Income | 6.95M | 2.13M | 292.00K | 58.00K | 1.05M | 101.00K | 91.00K | 72.00K | 19.00K | 6.00K | 16.00K | 38.00K | 30.00K | 27.00K | 162.00K | 648.00K | 300.00K | 300.00K | - | - | - | - |
| Pretax Income | -70.71M | -102.25M | -58.42M | -45.39M | -56.79M | -53.17M | -18.48M | -21.70M | 6.44M | -13.48M | -12.02M | -25.00M | -8.85M | 8.78M | -3.46M | -76.15M | -127.20M | -27.98M | -11.49M | -5.22M | -3.60M | -2.25M |
| Net Income | -70.80M | -124.51M | -63.91M | -52.65M | -62.97M | -53.17M | -18.48M | -21.55M | 6.35M | -13.36M | -11.90M | -24.84M | -8.63M | 8.75M | -2.51M | -75.67M | -103.67M | -20.91M | -11.18M | -2.56M | -1.86M | -2.25M |
| Selling & General & Admin | 51.79M | 60.32M | 53.08M | 46.02M | 47.71M | 13.06M | 11.23M | 9.01M | 8.06M | 7.47M | 7.17M | 6.87M | 8.10M | 6.97M | 8.79M | 13.95M | 12.98M | 15.88M | 3.81M | 1.60M | 565.51K | - |
| Research & Development | 64.66M | 49.64M | 28.50M | 17.42M | 15.37M | 16.18M | 14.88M | 14.38M | 12.09M | 9.57M | 7.00M | 7.04M | 6.86M | 6.99M | 8.01M | 14.43M | 20.03M | 11.70M | 6.29M | 4.87M | 3.08M | 1.80M |
| Other Expenses | - | 2.05M | 2.46M | 2.46M | 2.46M | 14.84M | 8.31M | 13.98M | 3.00K | 7.26M | 6.22M | 19.79M | 3.25M | 3.25M | - | 71.20M | 4.76M | 1.56M | 781.71K | 27.35K | 25.42K | - |
| Operating Expenses | 115.05M | 112.02M | 84.04M | 65.90M | 65.54M | 29.23M | 26.11M | 23.39M | 20.14M | 17.04M | 14.17M | 13.91M | 14.97M | 13.96M | 16.80M | 28.38M | 37.78M | 29.14M | 10.88M | 6.50M | 3.67M | 1.80M |
| Interest Expense | 1.25M | 3.19M | 5.50M | 7.26M | 6.18M | 720.00K | 720.00K | - | - | 1K | 2.00K | - | 1K | 13.00K | - | 507.00K | 1.94M | 3.37M | 3.37M | 3.92K | 3.92K | - |
| Selling & Marketing Expenses | 11.69M | 25.51M | 27.50M | 25.29M | 29.77M | 1.51M | 1.51M | - | - | - | - | - | - | - | - | - | -969.00K | - | - | - | - | - |
| Cost & Expenses | 121.08M | 120.34M | 92.22M | 71.73M | 68.23M | 29.23M | 26.11M | 23.39M | 20.14M | 17.04M | 14.17M | 13.91M | 14.97M | 13.96M | 16.80M | 28.38M | 37.78M | 29.14M | 10.88M | 6.50M | 3.67M | 1.80M |
| Income Tax | 83.00K | 22.26M | 5.50M | 7.26M | 6.18M | -25.56M | -815.00K | -155.00K | 96.00K | -130.00K | -117.00K | -169.00K | -218.00K | 23.00K | -951.00K | -483.00K | -23.53M | -7.07M | -303.15K | -2.67M | -1.74M | -1.80M |
| Shares Outstanding (Basic) | 38.90M | 37.32M | 28.76M | 12.84M | 10.43M | 4.62M | 3.53M | 3.16M | 2.94M | 2.74M | 2.30M | 2.08M | 1.95M | 1.84M | 1.83M | 1.82M | 1.10M | 752.10K | 519.50K | 3.06M | 253.65K | 410.92K |
| Shares Outstanding (Diluted) | 38.90M | 37.32M | 28.76M | 12.84M | 10.43M | 4.62M | 3.53M | 3.16M | 3.06M | 2.74M | 2.30M | 2.08M | 1.95M | 1.89M | 1.83M | 1.82M | 1.10M | 752.10K | 519.50K | 1.23M | 253.65K | 410.92K |
| EPS (Basic) | -1.82 | -3.34 | -2.22 | -4.1 | -6.04 | -11.5 | -5.23 | -6.81 | 2.16 | -4.87 | -5.16 | -11.95 | -4.43 | 4.76 | -1.37 | -41.65 | -93.93 | -27.81 | -21.53 | -0.84 | -7.32 | -5.48 |
| EPS (Diluted) | -1.82 | -3.34 | -2.22 | -4.1 | -6.04 | -11.5 | -5.23 | -6.81 | 2.08 | -4.87 | -5.16 | -11.95 | -4.43 | 4.63 | -1.37 | -41.65 | -93.93 | -27.81 | -21.53 | -2.08 | -7.32 | -5.48 |
| EBITDA | -69.00M | -96.62M | -50.15M | -35.49M | -48.01M | -36.99M | -18.58M | -17.67M | -20.87M | 7.30M | -12.65M | -11.04M | -22.78M | -5.49M | 9.09M | -24.00K | -75.65M | -22.05M | -18.98M | -9.44M | -6.00M | -3.39M |
| Depreciation & Amortization | 464.00K | 2.45M | 2.77M | 2.65M | 2.60M | 2.65M | 815.00K | 815.00K | 882.00K | 917.00K | 994.00K | 2.23M | 3.35M | 3.33M | 3.44M | 397.00K | 8.72M | 8.70M | 1.24M | 240.94K | 212.09K | 516.32K |